Microsurgical Resection of Vestibular Schwannoma after Failed Previous Surgery

Objective: The authors report their experience with 53 cases of surgically treated recurrent VS. Outcome of these tumors was compared with that of primarily operated on VS. Special attention was given to the facial nerve functional outcome.

Methods: A retrospective analysis was performed of the patients who underwent surgery for recurrent VS at one institution from 2000 to 2013. The clinical data was analyzed and compared with those in a control group of 30 randomly selected patients with primarily operated VS. A multivariate regression analysis was performed to test the factors that could affect the facial nerve outcome in each group.

Results: Fifty-three patients underwent surgery for recurrent VS. Seventeen patients were previously operated on and received postoperative radiosurgery (Group A). Thirty-six patients were previously operated on but did not receive postoperative radiosurgery (Group B). The overall postoperative facial nerve function was significantly worse in Groups A and B in comparison with the control group (Group C). Interestingly, there was no significant difference in the facial nerve outcome among the 3 groups in patients who had good preoperative facial nerve function. The tumor size and the preoperative facial nerve function are variables that significantly affect the facial nerve outcome. Most of the patients showed improvement of the preoperative symptoms, such as trigeminal hypesthesia, gait disturbance, and headache.

Conclusion: Complete microsurgical tumor removal is the optimal management for patients with recurrent or regrowing VS. The procedure is safe, associated with favorable facial nerve outcome, and may also improve existing neurological symptoms.